Yibing Chen

2.0k total citations · 2 hit papers
54 papers, 1.6k citations indexed

About

Yibing Chen is a scholar working on Molecular Biology, Artificial Intelligence and Finance. According to data from OpenAlex, Yibing Chen has authored 54 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Artificial Intelligence and 7 papers in Finance. Recurrent topics in Yibing Chen's work include Geological and Geochemical Analysis (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Mitochondrial Function and Pathology (4 papers). Yibing Chen is often cited by papers focused on Geological and Geochemical Analysis (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Mitochondrial Function and Pathology (4 papers). Yibing Chen collaborates with scholars based in China, United States and United Kingdom. Yibing Chen's co-authors include Aiqin Hu, Guoxin Zhang, Qian‐Feng Zhang, Bor‐ming Jahn, Lei Du, Xiaoxing Yin, Qian Lü, Hao Yang, Xizhi Li and Yi‐Gang Xu and has published in prestigious journals such as Nature Communications, Chemical Communications and Scientific Reports.

In The Last Decade

Yibing Chen

50 papers receiving 1.6k citations

Hit Papers

Crustal evolution and Phanerozoic crustal growth in north... 2000 2026 2008 2017 2000 2024 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yibing Chen China 22 734 487 371 121 104 54 1.6k
Qi Guan China 20 446 0.6× 190 0.4× 383 1.0× 35 0.3× 54 0.5× 99 1.5k
Xuan Liu China 30 1.7k 2.3× 1.2k 2.4× 445 1.2× 147 1.2× 398 3.8× 108 2.9k
Neng Jiang China 28 1.8k 2.4× 851 1.7× 365 1.0× 168 1.4× 279 2.7× 87 2.5k
Lingmin Zhang China 21 256 0.3× 91 0.2× 576 1.6× 266 2.2× 43 0.4× 65 1.3k
Bao Wang China 25 22 0.0× 110 0.2× 557 1.5× 161 1.3× 3 0.0× 107 1.8k
Shuang Hao China 13 330 0.4× 228 0.5× 291 0.8× 231 1.9× 40 0.4× 33 959
Robert W. Sullivan United States 16 134 0.2× 62 0.1× 117 0.3× 38 0.3× 17 0.2× 33 646
Huan Dong China 15 73 0.1× 34 0.1× 300 0.8× 117 1.0× 26 0.3× 29 815
Mengjie Wang China 14 11 0.0× 37 0.1× 302 0.8× 172 1.4× 13 0.1× 46 795

Countries citing papers authored by Yibing Chen

Since Specialization
Citations

This map shows the geographic impact of Yibing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yibing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yibing Chen more than expected).

Fields of papers citing papers by Yibing Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yibing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yibing Chen. The network helps show where Yibing Chen may publish in the future.

Co-authorship network of co-authors of Yibing Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yibing Chen. A scholar is included among the top collaborators of Yibing Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yibing Chen. Yibing Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yibing, Qian Jiang, Xiaowei Xing, et al.. (2025). Macrophage Derived Galectin‐3 Promotes Renal Fibrosis and Diabetic Kidney Disease by Enhancing TGFβ1 Signaling. Advanced Science. 12(35). e04032–e04032. 3 indexed citations
2.
Li, Linlin, Jialin Zhang, Huiqing Li, et al.. (2025). Targeted inhibition of JMJD2C/MALAT1 axis compensates for the deficiency of metformin in reversing ovarian cancer platinum resistance. Life Sciences. 373. 123663–123663. 2 indexed citations
3.
Kong, Lijuan, Xiaojing Jiang, Qian Jiang, et al.. (2024). Trimethylamine N-oxide impairs β-cell function and glucose tolerance. Nature Communications. 15(1). 2526–2526. 44 indexed citations breakdown →
4.
Chen, Yibing, Chunxiao Ma, Xiaohong Peng, et al.. (2024). Galectin-3 impairs calcium transients and β-cell function. Nature Communications. 15(1). 3682–3682. 15 indexed citations
6.
Hou, Shaocong, Andrew M. Johnson, Xingfeng Liu, et al.. (2024). Intestinal epithelial cell NCoR deficiency ameliorates obesity and metabolic syndrome. Acta Pharmaceutica Sinica B. 14(12). 5267–5285.
7.
Chen, Yibing, et al.. (2024). Clinical research progress on β-cell dysfunction in T2DM development in the Chinese population. Reviews in Endocrine and Metabolic Disorders. 26(1). 31–53. 6 indexed citations
8.
Chen, Yibing, et al.. (2024). Simvastatin alleviates glymphatic system damage via the VEGF-C/VEGFR3/PI3K-Akt pathway after experimental intracerebral hemorrhage. Brain Research Bulletin. 216. 111045–111045. 33 indexed citations
9.
Li, Bo, Yibing Chen, Ning Wang, et al.. (2024). Discovery of 4,5-dihydro-benzo[g]indazole-based hydroxamic acids as HDAC3/BRD4 dual inhibitors and anti-tumor agents. European Journal of Medicinal Chemistry. 285. 117230–117230. 5 indexed citations
10.
Liu, Chunlei, Guo Ge, Xin Li, et al.. (2023). Identification of novel urine proteomic biomarkers for high stamina in high-altitude adaptation. Frontiers in Physiology. 14. 1153166–1153166.
11.
Du, Lei, Yibing Chen, Xue Wang, et al.. (2022). Inhibition of S100A8/A9 ameliorates renal interstitial fibrosis in diabetic nephropathy. Metabolism. 144. 155376–155376. 43 indexed citations
12.
Yang, Tingting, Hao Yang, Heng Cai, et al.. (2019). YY1: A novel therapeutic target for diabetic nephropathy orchestrated renal fibrosis. Metabolism. 96. 33–45. 42 indexed citations
13.
Du, Lei, Jin Wang, Yibing Chen, et al.. (2019). Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy. Cell Biology and Toxicology. 36(3). 243–260. 41 indexed citations
14.
Du, Lei, Chengcheng Li, Yibing Chen, et al.. (2019). Quercetin inhibited mesangial cell proliferation of early diabetic nephropathy through the Hippo pathway. Pharmacological Research. 146. 104320–104320. 108 indexed citations
15.
Du, Lei, Lei Wang, Bo Wang, et al.. (2019). A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling. Acta Pharmacologica Sinica. 41(3). 358–372. 38 indexed citations
16.
Chen, Yibing, Xu Guo, Feng Zhou, et al.. (2016). Genetic variants in glucose-6-phosphate isomerase gene as prognosis predictors in hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology. 40(6). 698–704. 13 indexed citations
17.
Qu, Falin, Yibing Chen, Xin Wang, et al.. (2015). Leukocyte mitochondrial DNA content: a novel biomarker associated with prognosis and therapeutic outcome in colorectal cancer. Carcinogenesis. 36(5). 543–552. 21 indexed citations
18.
Zhang, Jie, Deyang Li, Falin Qu, et al.. (2014). Association of leukocyte mitochondrial DNA content with glioma risk: evidence from a Chinese case–control study. BMC Cancer. 14(1). 680–680. 21 indexed citations
19.
Chen, Yibing. (2012). Zircons LA-ICP-MS U-Pb Dating on the Baluntai Deformed Granitoids, Central Tianshan Block, Northwest China, and Its Tectonic Implications. Dizhi lunping. 20 indexed citations
20.
Pan, Ke, MinShan Chen, Jianjun Li, et al.. (2010). Decreased expression of XPO4 is associated with poor prognosis in hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 26(3). 544–549. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026